Related Experiment Video

Updated: May 13, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

A potential therapeutic strategy for malignant mesothelioma with gene medicine

Yuji Tada1, Hideaki Shimada, Kenzo Hiroshima

  • 1Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.

Biomed Research International
|March 14, 2013
PubMed

Insights

Gene therapy shows promise for malignant mesothelioma treatment, offering a localized approach. Overcoming challenges like low efficiency and immune response is key for future clinical success.

Area of Science:

  • Oncology
  • Gene Therapy
  • Immunology

Background:

  • Malignant mesothelioma, linked to asbestos exposure, presents a growing global health challenge.
  • Current treatments offer limited efficacy for survival and quality of life.
  • Localized treatments, like gene therapy, are being explored for thoracic mesothelioma.

Purpose of the Study:

  • To review the current status of preclinical and clinical gene therapy for malignant mesothelioma.
  • To discuss future clinical directions for gene medicine in mesothelioma treatment.

Main Methods:

  • Review of preclinical studies on gene medicine for mesothelioma.
  • Analysis of clinical trials using adenovirus vectors for intrapleural administration.
  • Examination of challenges including transduction efficiency and anti-vector antibody generation.

Main Results:

  • Preclinical studies indicate gene therapy's efficacy for mesothelioma.
  • Clinical trials demonstrate the safety of intrapleural vector injection and potential antitumor immune responses.
  • Low transduction efficiency and rapid anti-vector antibody generation are significant hurdles.

Conclusions:

  • Gene therapy, particularly with intrapleural vector administration, is a potential therapeutic strategy for malignant mesothelioma.
  • Combinatorial approaches using gene medicine with anticancer agents or immunotherapy may enhance clinical outcomes.
  • Further research is needed to overcome current limitations for broader clinical application.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.